Could Greater Transparency Improve Pharmaceutical Quality and Compliance?
Could greater market transparency improve pharmaceutical quality and regulatory compliance?
A new website and methodology would rank manufacturers based on quality and good manufacturing and business practices. Martin Van Trieste discusses the principles behind medicine-i.com, which he has started up, using software designed by Richard Love, CEO of HarborView.
The site will be driven by algorithms that take quality, compliance and shortages data and rank suppliers based on their level of control in each area.
Download Pharmaceutical Technology’s
2016 Quality Throughout the Supply Chain eBook.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
